Can significant results in the primary outcome of a pilot RCT (n = 50) with prespecified confirmatory analysis be interpreted as class 1 evidence as it would have been in a full scale trial? That means, is it possible to conclude from a pilot trial that a significant effect in the primary outcome means that the intervention improves the targeted outcome or is it still necessary to run a larger full-scale trial to confirm the hypothesis again?